1.
Papp K, Szepietowski J, Kircik L, Toth D, Kuligowski M, Venturanza M, Sun K, Simpson E. Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Pooled Analysis of Two Phase 3, Randomized, Double-Blind Studies. J of Skin [Internet]. 2021Jan.1 [cited 2021Dec.2];5(1):s8. Available from: https://www.jofskin.org/index.php/skin/article/view/1161